Skip to search
Skip to main content
Back to Search
Start Over
Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial
Authors :
MS Hematologie Infection & Immunity Regenerative Medicine and Stem Cells Cancer Wester, Ruth van der Holt, Bronno Asselbergs, Emelie Zweegman, Sonja Kersten, Marie Jose Vellenga, Edo Kooy, Marinus van Marwijk de Weerdt, Okke Minnema, Monique Lonergan, Sarah Palumbo, Antonio Lokhorst, Henk Broijl, Annemiek Sonneveld, Pieter MS Hematologie Infection & Immunity Regenerative Medicine and Stem Cells Cancer Wester, Ruth van der Holt, Bronno Asselbergs, Emelie Zweegman, Sonja Kersten, Marie Jose Vellenga, Edo Kooy, Marinus van Marwijk de Weerdt, Okke Minnema, Monique Lonergan, Sarah Palumbo, Antonio Lokhorst, Henk Broijl, Annemiek Sonneveld, Pieter
Publication Year :
2019
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1395296922
Document Type :
Electronic Resource